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Abstract
Introduction: In cases of patients with disseminated lymphadenopathy, the differential diagnosis
has to include both benign and malignant causes, including sarcoidosis, metastatic disease,
lymphoma and, although rarely present, tuberculosis. Tuberculosis is still one of the most
frequently occurring infectious diseases worldwide. However, disseminated mycobacterial
lymphadenitis is rare in immunocompetent patients.
Case presentation: We present the case of a 56-year-old Caucasian Greek male, who was
immunocompetent and HIV negative, with a two-month history of recurring fever, loss of appetite
and disseminated lymphadenopathy. The patient was diagnosed with mycobacterial
lymphadenopathy.
Conclusion: This case highlights the need for suspicion in order to identify mycobacterial infection
in patients with generalized lymphadenopathy, since misdiagnosis is possible and may lead to fatal
complications for the patient.
Introduction
Disseminated lymphadenopathy presents a diagnostic
dilemma and the differential diagnosis has to include
tuberculosis (TB), although rarely present. TB is still one
of the most frequently occurring infectious diseases
worldwide. According to the World Health Organization,
approximately one third of the world's population is
infected with tubercle bacilli. Eight million new cases of
the active disease develop each year and three million
people die from it [1]. Mycobacterial lymphadenitis com-
prises about 2% to 5% of all cases of TB and is more com-
mon among children, women and minorities, as well as in
immunosuppressed patients, especially those with HIV
[2,3]. The cervical lymph nodes are most frequently
involved, followed by the mediastinal lymph nodes and
the axillary lymph nodes. Disseminated mycobacterial
lymphadenopathy, meanwhile, is extremely rare in non-
HIV patients. As this kind of disseminated lymphadenop-
athy is of good prognosis due to antituberculous medica-
tion, diagnosis has to be confirmed by histologic and
microbiological analyses. A possible misdiagnosis may
lead to fatal complications for the patient [2,3].
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We present the case of a 56-year-old Caucasian Greek
male, who was immunocompetent and HIV negative, but
had a two-month history of recurring fever, loss of appe-
tite and polylymphadenopathy. The patient was diag-
nosed with mycobacterial lymphadenopathy. This case
highlights the need for additional scrutiny to reach this
diagnosis.
Case presentation
A 56-year-old Caucasian Greek male was referred to the
emergency department of our hospital with a two-month
history of recurring fever, loss of appetite and swelling in
his neck.
Upon admission, he was obtunded and hyperthermic
(axillary temperature, 38°C). The patient had a respira-
tory rate of 20 breaths/min and a heart rate of 100 beats/
min. He had no skin lesions. Upon physical examination,
he was found to have bilateral cervical, axillary and
inguinal lymphadenopathy. His lymph nodes were tena-
cious, unmovable and tender, and measured from 1.0 ×
1.5 cm to 3.0 × 3.5 cm. A respiratory examination revealed
mild bilateral inspiratory fine crackles. Chest X-rays
showed right hilar lymphadenopathy. Laboratory data
showed hemoglobin levels at 10.81 g/dl, a white blood
cell count of 6,800 cells/mm3 (70% neutrophils, 14%
lymphocytes, 12% monocytes, 1% eosinophils) and a
platelet count of 346.000 cells/mm3. His international
normalized ratio was 1.11 and his activated partial throm-
boblastin time was 32.8 seconds.
The patient's erythrocyte sedimentation rate was 64 mm/
h, and his C-reactive protein concentration was 9.97 mg/
dl (normal range < 0.6 mg/dl). His total bilirubin was
0.13 mg/dl, his serum glutamic oxaloacetic transaminase
(SGOT) was 113 IU/l, his serum glutamic pyruvic
transaminase (SGPT) was 36 IU/l, his total protein was
7.69 mg/dl, and his creatinine phosphokinase (CPK) was
1777 IU/l. His renal function tests were within normal
ranges, and an examination of his cerebrospinal fluid
revealed no cells and its biochemical composition was
normal. A Mantoux test was positive (20 mm), an arterial
blood gas analysis while breathing room air showed pH
7.39, PaO277 mmHg, PaCO2 40.6 mmHg, and HCO3
25.1 mmol/l. A protein electrophoresis did not show any
monoclonal spike. Serolologic tests for hepatitis A, B, and
C viruses and HIV were negative.
An ultrasonography of the abdomen revealed hepat-
osplenomegaly and a computed tomography (CT) of the
brain demonstrated no evidence of parenchymal lesions.
A CT scan of the neck showed multiple enlarged lymph
nodes in the right cervical chain, measuring up to 3.5 cm
(Figure 1). A chest CT scan revealed numerous paratra-
cheal lymph nodes over the superior-anterior mediasti-
num, measuring up to 2.8 cm (Figure 2). An abdominal
CT showed lymph nodes in the lesser omentum, the
mesentery, the anterior pararenal space, and the upper
and lower para-aortic regions, measuring up to 2.5 cm
(Figure 3).
Cervical lymph node and bone marrow biopsies were per-
formed. The bone marrow biopsy was normocellular with
mature hematopoietic elements. The lymph node was
completely effaced with a lot of epithelioid cells and occa-
sional Langhans giant cells, constituting well-defined
granulomas with caseous necrosis, typical of TB. Immu-
nohistochemically, the cells were negative for CD3,
CD20, CD30, kappa and light chains. A Ziehl-Neelsen
stain for acid-fast bacilli (AFB) was negative, but the cul-
ture grew Mycobacterium tuberculosis complex. The
patient was started on antituberculous treatment with the
standard four-drug regimen consisting of rifampin,
pyrazinamide, ethambutol and isoniazid. After two
months of treatment, he was symptom-free, with a prom-
inent reduction in most lymph node swelling. The patient
was started on a two-drug regimen of isoniazid and
rifampin for seven months. At the end of the therapy, the
patient had residual lymph nodes in the neck and in the
mediastinum.
The computed tomography scan of the neck shows an  enlarged right submaxillary lymph node Figure 1
The computed tomography scan of the neck shows 
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Discussion
We present the case of a 56-year-old immunocompetent
man with cervical, mediastinal, axillar, inguinal and
abdominal lymphadenopathy, in whom tuberculous lym-
phadenopathy was diagnosed. Disseminated lymphaden-
opathy represents a challenge to a majority of clinicians
and may be caused by a vast array of diseases, including
mycobacterial infection.
TB is the foremost cause of death from a single infectious
agent in humans. According to recent estimates, one per-
son is newly infected with TB bacilli every second world-
wide, and one third of the global population is currently
infected with TB [1]. Poverty, HIV and drug resistance are
major contributors to the resurging global TB epidemic.
Approximately 95% of TB cases occur in developing coun-
tries. Approximately one in 14 new TB cases occurs in
individuals infected with HIV, with 85% of these cases
occurring in Africa [4,5].
While the primary site of infection in TB is the lungs, in up
to 15% of cases an extrapulmonary site may produce the
first symptoms [2]. Extrapulmonary TB is more common
in children, women and minorities [6,7]. Lymphadenitis
is the most common extrapulmonary presentation of TB.
It occurs most commonly in the cervical region, represent-
ing 63% of all tuberculous lymphadenitis in one study of
1161 patients [2]. In the same study, the incidence of
lymph node swelling detected in more than one site was
35.0%, whereas the incidence of inguinal lymph nodes
was only 1.7% [2]. Although previously considered a
childhood disease, lymphadenitis has a peak age of onset
of 20 to 40 years [8,9]. Interestingly, in our case, a 56-year-
old immunocompetent man who was HIV-negative had
generalized lymphadenopathy including swollen
inguinal lymph nodes.
The nodes in patients with mycobacterial lymhaphaden-
opathy are discrete, firm and non-tender. In time, a firm
mass of matted nodes becomes visible. Hard, fixed nodes
can be found in cancers and firm, rubbery nodes in lym-
phomas. If untreated, the tuberculous nodes become fluc-
tuant and drain spontaneously with sinus tract formation.
Patients with mycobacterial lymphadenopathy usually
present with fever, night sweats and weight loss. Most
patients have positive tuberculin skin test results and nor-
mal chest radiographs. An excisional biopsy of the lymph
nodes with a histology, AFB stain and mycobacterial cul-
ture is the best diagnostic procedure [10]. The use of fine-
needle aspirations in patients without HIV infections is
highly variable [8]. A polymerase chain reaction for Myco-
bacterium tuberculosis of the fine needle aspiration speci-
men enhances test sensitivity [11].
A 6- to 9-month regimen (2 months of isoniazid,
rifampin, pyrazinamide, and ethambutol, followed by 4
to 7 months of isoniazid and rifampin), is recommended
as initial therapy for all forms of extrapulmonary TB,
unless the organisms are known or strongly suspected to
be resistant to first-line drugs [12]. During antitubercu-
lous therapy, affected nodes may enlarge or new nodes
may appear, representing an immune response to killed
mycobacteria. This phenomenon may lead to doubts
about the accuracy of the diagnosis among inexperienced
observers; however, since the enlargement of the lymph
nodes during therapy is not unusual, it does not represent
A computed tomography scan of the chest showing enlarged  paratracheal lymph nodes over the superior anterior medi- astinum Figure 2
A computed tomography scan of the chest showing 
enlarged paratracheal lymph nodes over the superior 
anterior mediastinum.
An abdominal computed tomography scan showing para-aor- tic lymphadenopathy Figure 3
An abdominal computed tomography scan showing 
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a sign of treatment failure [13]. Lymph node excision in
the M. tuberculosis complex disease is not usually indi-
cated. Relapse rates of up to 3.5% have been reported in
patients treated for TB lymphadenitis [14]. A minority of
adequately treated patients will have residual lymph
nodes present at the end of the planned treatment course.
Conclusion
Disseminated lymphadenopathy represents a major diag-
nostic problem. The differential diagnosis in an immuno-
competent adult includes sarcoidosis, metastatic disease,
lymphoma and, although rarely present, TB. Generalized
lymph node involvement is uncommon in TB. In view of
its relatively rare nature but accurate prognosis due to
antituberculous medication, it is important to distinguish
tuberculous lymphadenopathy in adults from other
causes of generalized lymphadenopathy.
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